BOSTON SCIENTIFIC CORP — Director's Dealing 2020

Feb 24, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2020-02-21

Reporting Person: Monson Jonathan (VP, Corp Controller and CAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-21	Common Stock	M	623.0000	$0.0000	Acquired	32750.0000	Direct
2020-02-21	Common Stock	F	223.0000	$42.6200	Disposed	32527.0000	Direct
2020-02-22	Common Stock	M	1159.0000	$0.0000	Acquired	33686.0000	Direct
2020-02-22	Common Stock	F	387.0000	$42.6200	Disposed	33299.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-21	Deferred Stock Units	$	M	623.0000	Disposed	2023-02-21	Common Stock (623.0000)	Direct
2020-02-22	Deferred Stock Units	$	M	1159.0000	Disposed	2021-02-22	Common Stock (1159.0000)	Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.

F3: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.